<DOC>
	<DOC>NCT00888264</DOC>
	<brief_summary>The purpose of this NIS is to obtain data on how AAPs are used in DSM-IV-TR Bipolar I and II Disorder, in the course of a major depressive episode. Both the parameters of use of AAPs and clinical evaluation will be recorded and potential differences that may exist due to epidemiological factors or comorbidities will be analyzed.</brief_summary>
	<brief_title>A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Outpatients, diagnosed with Bipolar I or II Disorder, having presented or presenting a major depressive episode (according to DSMIVTR) with a starting date of 6 months maximum before the inclusion. Current treatment with atypical antipsychotic(s) (AAP(s)) minimal 1 month and maximum 6 months prior to the first study visit Patient takes an AAP at an adequate therapeutic dose as indicated in the local Summary of Product Characteristics (SPC) and current medical practice Patients diagnosed with Bipolar I or II, experiencing a hypomanic, manic or mixed episode at time of inclusion Pregnant or breastfeeding women, or women of childbearing potential not using a medical reliable method of contraception as stated in the SPC of the AAPs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Antipsychotics</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Depressive episodes</keyword>
	<keyword>Bipolar I or II Disorders</keyword>
</DOC>